[go: up one dir, main page]

TW273515B - - Google Patents

Info

Publication number
TW273515B
TW273515B TW082102782A TW82102782A TW273515B TW 273515 B TW273515 B TW 273515B TW 082102782 A TW082102782 A TW 082102782A TW 82102782 A TW82102782 A TW 82102782A TW 273515 B TW273515 B TW 273515B
Authority
TW
Taiwan
Prior art keywords
prepn
clodronate
dissolves
film
acceptable salt
Prior art date
Application number
TW082102782A
Other languages
English (en)
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of TW273515B publication Critical patent/TW273515B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW082102782A 1992-04-24 1993-04-13 TW273515B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201299A SE501389C2 (sv) 1992-04-24 1992-04-24 Farmaceutiskt preparat och förfarande för dess framställning

Publications (1)

Publication Number Publication Date
TW273515B true TW273515B (zh) 1996-04-01

Family

ID=20386054

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082102782A TW273515B (zh) 1992-04-24 1993-04-13

Country Status (21)

Country Link
US (1) US5525354A (zh)
EP (1) EP0637236B1 (zh)
JP (1) JP3536106B2 (zh)
AT (1) ATE143802T1 (zh)
AU (1) AU671830B2 (zh)
CA (1) CA2134196C (zh)
CZ (1) CZ282871B6 (zh)
DE (2) DE69305335T2 (zh)
DK (1) DK0637236T3 (zh)
EE (1) EE03107B1 (zh)
ES (1) ES2094539T3 (zh)
FI (1) FI110667B (zh)
GR (1) GR3022249T3 (zh)
HK (1) HK13097A (zh)
HU (1) HU219342B (zh)
IL (1) IL105403A (zh)
NO (1) NO306654B1 (zh)
RU (1) RU2116074C1 (zh)
SE (1) SE501389C2 (zh)
TW (1) TW273515B (zh)
WO (1) WO1993021907A1 (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
ES2065313T5 (es) * 1993-05-15 2004-01-01 Roche Diagnostics Gmbh Tableta con biodisponibilidad mejorada que contiene acido diclorometilendifosfonico como sustancia activa.
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
FI98343C (fi) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Peroraalinen formulaatio
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
EP0998932A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
EP0998933A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
ES2301477T3 (es) * 1999-02-22 2008-07-01 Merrion Research I Limited Forma de dosificacion oral solida que contiene un potenciador.
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
CA2446619C (en) 2001-05-11 2011-04-26 Elan Corporation, Plc Permeation enhancers
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
KR101191322B1 (ko) 2006-04-07 2012-10-16 메리온 리서치 Ⅲ 리미티드 증진제를 함유하는 고형 경구용 투여 제형
CA2723558A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of gnrh related compounds and processes of preparation
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
US8802114B2 (en) 2011-01-07 2014-08-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
WO2016120378A1 (en) 2015-01-29 2016-08-04 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
JP2782691B2 (ja) * 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

Also Published As

Publication number Publication date
EP0637236A1 (en) 1995-02-08
US5525354A (en) 1996-06-11
CZ282871B6 (cs) 1997-11-12
HK13097A (en) 1997-02-14
DE69305335D1 (de) 1996-11-14
NO944001D0 (no) 1994-10-21
IL105403A (en) 1998-03-10
GR3022249T3 (en) 1997-04-30
FI944961L (fi) 1994-10-21
DK0637236T3 (da) 1997-03-17
CZ261494A3 (en) 1995-02-15
FI110667B (fi) 2003-03-14
ATE143802T1 (de) 1996-10-15
ES2094539T3 (es) 1997-01-16
IL105403A0 (en) 1993-08-18
DE637236T1 (de) 1995-07-06
NO944001L (no) 1994-10-21
SE501389C2 (sv) 1995-01-30
EP0637236B1 (en) 1996-10-09
SE9201299L (sv) 1993-10-25
WO1993021907A1 (en) 1993-11-11
HU9403067D0 (en) 1994-12-28
JPH07505898A (ja) 1995-06-29
FI944961A0 (fi) 1994-10-21
RU2116074C1 (ru) 1998-07-27
JP3536106B2 (ja) 2004-06-07
AU671830B2 (en) 1996-09-12
CA2134196A1 (en) 1993-11-11
HU219342B (en) 2001-03-28
SE9201299D0 (sv) 1992-04-24
EE03107B1 (et) 1998-08-17
NO306654B1 (no) 1999-12-06
DE69305335T2 (de) 1997-04-30
CA2134196C (en) 2004-02-10
HUT74572A (en) 1997-01-28
AU3955093A (en) 1993-11-29
RU94045950A (ru) 1996-11-10

Similar Documents

Publication Publication Date Title
TW273515B (zh)
ES2144077T3 (es) Formas de administracion que contienen sales solidas de acido r-tioctico con liberacion y biodisponibilidad mejoradas.
SE9202250D0 (sv) Controlled release morphine preparation
ES2219028T3 (es) Uso de bisfosfonatos para el tratamiento de restenosis vascular.
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
UA41909C2 (uk) Використання комбінації сполук для інгібірування остеопорозу, фармацевтичний препарат
DE69631609D1 (en) Tricyclische erythromycinderivate
SI1105105T1 (sl) Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole
IT1285079B1 (it) Sistema attuatore per la compensazione dell'allineamento di una macchina.
AU4702093A (en) More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
IL118299A (en) Use of AII-receptor antagonists for the manufacture of a medicament with effect on multiple system organ failure
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
EP0824341A4 (en) PREVENTING TOOTH LOSS THROUGH ADMINISTRATION OF ALENDRONATE OR ITS SALTS
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
CA2057456A1 (en) Anti depression pharmaceutical
ITPN920071A0 (it) Sistema di bloccaggio dell'orientamento a 360° del moncone preangolato per implantologia orale.
CA2606885A1 (en) Micro-pin for a drug-release system
IS1881B (is) 2,4-dísúlfónýlfenýlbútýlnítrón, sölt þess, lyfjablanda ásamt notkun á þessu efnasambandi við framleiðslu á lyfi